For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Codiak Biosciences, Inc.

USPTO Granted Patents = 13

EPO Patents = 3

Trademarks = 2

Forward Citations = 63

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Douglas E Williams (5 out of 17 patents)

Jan Lötvall (5 out of 6 patents)

John D Kulman (4 out of 21 patents)

4. Ke Xu (3 out of 9 patents)

5. Hadi Valadi (3 out of 4 patents)

6. Kevin P Dooley (3 out of 6 patents)

7. Sriram Sathyanarayanan (2 out of 9 patents)

8. Rane A Harrison (2 out of 5 patents)

9. Russell E McConnell (2 out of 4 patents)

10. Damian J Houde (2 out of 6 patents)

11. Nikki Ross (2 out of 6 patents)

12. Sonya Haupt (2 out of 4 patents)

13. Jonas Andrej Nilsson (2 out of 2 patents)

14. Nuruddeen D Lewis (1 out of 3 patents)

15. Yu Zhou (1 out of 3 patents)

13 patents: Sort by Forward Citations

1. 12746291 - METHODS OF LOADING EXTRACELLULAR VESICLES (2026-09-29),

2. 12648907 - MEMBRANE PROTEIN SCAFFOLDS FOR EXOSOME ENGINEERING (2026-06-09),

3. 12622876 - METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN (2026-05-12),

4. 12616712 - STING AGONIST COMPRISING EXOSOMES FOR TREATING NEUROIMMUNOLOGICAL DISORDERS (2026-05-05),

5. 11679164 - Preparation of therapeutic exosomes using membrane proteins (2023-06-20),

6. 11512315 - Methods and compositions for macrophage polarization (2022-11-29),

7. 10723782 - Exosomes for immuno-oncology and anti-inflammatory therapy (2020-07-28),

8. 10695443 - Exosome transfer of nucleic acids to cells (2020-06-30),

9. 10370663 - Delivery of therapeutic agent (2019-08-06),

10. 10195290 - Preparation of therapeutic exosomes using membrane proteins (2019-02-05),

11. 9889210 - Exosome transfer of nucleic acids to cells (2018-02-13),

12. 9856477 - Delivery of therapeutic agent (2018-01-02),

13. 9629929 - Exosome transfer of nucleic acids to cells (2017-04-25),

Codiak Biosciences, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of exosome-based therapeutics. The company focuses on harnessing the natural properties of exosomes to create innovative treatments for various diseases, including cancer and genetic disorders. Codiak's proprietary platforms enable the engineering of exosomes for targeted delivery of therapeutics, positioning the company at the forefront of advancements in drug delivery systems and precision medicine.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Codiak Biosciences, Inc.

13 Patents

#192 in Cambridge, MA

#1,441 in Massachusetts

#23,815 in US

#44,988 in the World

Cambridge, MA, United States of America

Codiak Biosciences, Inc.

Forward Citations = 63

26 inventors:

Douglas E Williams (5 out of 17 patents)

Jan Lötvall (5 out of 6 patents)

John D Kulman (4 out of 21 patents)

4. Ke Xu (3 out of 9 patents)

5. Hadi Valadi (3 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…